Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: A systematic review and meta-analysis of randomized-controlled trials
© 2015 Elsevier Ltd. Limited options are available for clozapine-resistant schizophrenia and intolerable side effects of clozapine. We conducted a systematic review of randomized-controlled trials (RCTs) to determine the efficacy and safety of aripiprazole augmentation of clozapine for schizophrenia...
Saved in:
Main Authors: | Srisurapanont,M., Suttajit,S., Maneeton,N., Maneeton,B. |
---|---|
Format: | Article |
Published: |
Elsevier Limited
2015
|
Subjects: | |
Online Access: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84924289206&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38419 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Quetiapine monotherapy in acute phase for major depressive disorder: A meta-analysis of randomized, placebo-controlled trials
by: Maneeton N., et al.
Published: (2015) -
Clozapine combination and augmentation strategies in patients with schizophrenia - recommendations from an international expert survey among the treatment response and resistance in psychosis (TRRIP) working group
by: Wagner, Elias, et al.
Published: (2021) -
Comorbid personality disorders among patients with depression
by: Wongpakaran N., et al.
Published: (2015) -
The influence of comorbid personality disorders on recovery from depression
by: Wongpakaran T., et al.
Published: (2015) -
Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
by: Lim,A., et al.
Published: (2015)